يعرض 1 - 10 نتائج من 142 نتيجة بحث عن '"Fogli, S"', وقت الاستعلام: 0.85s تنقيح النتائج
  1. 1
    دورية أكاديمية
    MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development. an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view

    المؤلفون: Natalicchio, A, Montagnani, M, Gallo, M, Marrano, N, Faggiano, A, Zatelli, M C, Mazzilli, R, Argentiero, A, Danesi, R, D'Oronzo, S, Fogli, S, Giuffrida, D, Gori, S, Ragni, A, Renzelli, V, Russo, A, Franchina, T, Tuveri, E, Sciacca, L, Monami, M, Cirino, G, Di Cianni, G, Colao, A, Avogaro, A, Cinieri, S, Silvestris, N, Giorgino, F

    المساهمون: Natalicchio, A, Montagnani, M, Gallo, M, Marrano, N, Faggiano, A, Zatelli, M C, Mazzilli, R, Argentiero, A, Danesi, R, D'Oronzo, S, Fogli, S, Giuffrida, D, Gori, S, Ragni, A, Renzelli, V, Russo, A, Franchina, T, Tuveri, E, Sciacca, L, Monami, M, Cirino, G, Di Cianni, G, Colao, A, Avogaro, A, Cinieri, S, Silvestris, N, Giorgino, F

    مصطلحات موضوعية: cancer, mirna-based drug, mirna, type 2 diabetes

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37263082; info:eu-repo/semantics/altIdentifier/wos/WOS:001044705700001; volume:8; issue:3; firstpage:1; lastpage:17; numberofpages:17; journal:ESMO OPEN; https://hdl.handle.net/11573/1681794Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85162783248

    الإتاحة: https://doi.org/10.1016/j.esmoop.2023.101573Test
    https://hdl.handle.net/11573/1681794Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper

    المؤلفون: Silvestris, N., Franchina, T., Gallo, M., Argentiero, A., Avogaro, A., Cirino, G., Colao, A., Danesi, R., Di Cianni, G., D’Oronzo, S., Faggiano, A., Fogli, S., Giuffrida, D., Gori, S., Marrano, N., Mazzilli, R., Monami, M., Montagnani, M., Morviducci, L., Natalicchio, A., Ragni, A., Renzelli, V., Russo, A., Sciacca, L., Tuveri, E., Zatelli, M.C., Giorgino, F., Cinieri, S.

    المصدر: ESMO Open ; volume 8, issue 6, page 102062 ; ISSN 2059-7029

    مصطلحات موضوعية: Cancer Research, Oncology

    الإتاحة: https://doi.org/10.1016/j.esmoop.2023.102062Test
    https://api.elsevier.com/content/article/PII:S2059702923013030?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S2059702923013030?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    TGF-β mRNA Expression Levels in Extracellular Vesicles Are Associated With Immunotherapy Response in Metastatic Melanoma Patients

    المؤلفون: Crucitta, S., Cucchiara, F., Marconcini, R., Bulleri, A., Manacorda, S., Cioni, D., Nuzzo, A., De Jonge, E., Mathjissen, R., Neri, E., van Schaik, R., Fogli, S., Danesi, R., Del Re, M.

    المصدر: The Journal of Liquid Biopsy ; volume 1, page 100019 ; ISSN 2950-1954

    الإتاحة: https://doi.org/10.1016/j.jlb.2023.100019Test
    https://api.elsevier.com/content/article/PII:S295019542300019X?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S295019542300019X?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper

    المؤلفون: Faggiano A., Mazzilli R., Natalicchio A., Adinolfi V., Argentiero A., Danesi R., D'Oronzo S., Fogli S., Gallo M., Giuffrida D., Gori S., Montagnani M., Ragni A., Renzelli V., Russo A., Silvestris N., Franchina T., Tuveri E., Cinieri S., Colao A., Giorgino F., Zatelli M. C.

    المساهمون: Faggiano A., Mazzilli R., Natalicchio A., Adinolfi V., Argentiero A., Danesi R., D'Oronzo S., Fogli S., Gallo M., Giuffrida D., Gori S., Montagnani M., Ragni A., Renzelli V., Russo A., Silvestris N., Franchina T., Tuveri E., Cinieri S., Colao A., Giorgino F., Zatelli M.C.

    مصطلحات موضوعية: Adverse events, Cancer, Corticosteroids, Dose, Glucocorticoids, Indications, Survival, Tumour response, Settore MED/06 - Oncologia Medica

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36191821; info:eu-repo/semantics/altIdentifier/wos/WOS:000918010300011; volume:180; numberofpages:13; journal:CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; https://hdl.handle.net/10447/582211Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85139266547

    الإتاحة: https://doi.org/10.1016/j.critrevonc.2022.103826Test
    https://hdl.handle.net/10447/582211Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients

    المؤلفون: Del Re M., Omarini C., Diodati L., Palleschi M., Meattini I., Crucitta S., Lorenzini G., Isca C., Fontana A., Livi L., Piacentini F., Fogli S., De Giorgi U., Danesi R.

    المساهمون: Del Re, M., Omarini, C., Diodati, L., Palleschi, M., Meattini, I., Crucitta, S., Lorenzini, G., Isca, C., Fontana, A., Livi, L., Piacentini, F., Fogli, S., De Giorgi, U., Danesi, R.

    مصطلحات موضوعية: Drug Interaction, Female, Human, Piperazine, Pyridine, Breast Neoplasm, Proton Pump Inhibitors

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35131649; info:eu-repo/semantics/altIdentifier/wos/WOS:000819873600043; volume:7; issue:1; firstpage:1; lastpage:2; journal:ESMO OPEN; http://hdl.handle.net/11380/1280340Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123984743

    الإتاحة: https://doi.org/10.1016/j.esmoop.2022.100381Test
    http://hdl.handle.net/11380/1280340Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib

    المؤلفون: Del Re M., Crucitta S., Omarini C., Bargagna I., Mongillo M., Palleschi M., Stucci S., Meattini I., D'Onofrio R., Lorenzini G., Biondani P., De Giorgi U., Porta C., Livi L., Natalizio S., Fontana A., Giontella E., Angelini L., Fogli S., Danesi R.

    المساهمون: Del Re, M., Crucitta, S., Omarini, C., Bargagna, I., Mongillo, M., Palleschi, M., Stucci, S., Meattini, I., D'Onofrio, R., Lorenzini, G., Biondani, P., De Giorgi, U., Porta, C., Livi, L., Natalizio, S., Fontana, A., Giontella, E., Angelini, L., Fogli, S., Danesi, R.

    مصطلحات موضوعية: Breast cancer, Drug-drug interaction, PFS, Proton pump inhibitor, Ribociclib

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36283134; info:eu-repo/semantics/altIdentifier/wos/WOS:000878689800002; volume:66; firstpage:157; lastpage:161; journal:BREAST; https://hdl.handle.net/11380/1305347Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85140249242

    الإتاحة: https://doi.org/10.1016/j.breast.2022.10.005Test
    https://hdl.handle.net/11380/1305347Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards

    المؤلفون: Danesi R., Fogli S., Indraccolo S., Del Re M., Dei Tos A. P., Leoncini L., Antonuzzo L., Bonanno L., Guarneri V., Pierini A., Amunni G., Conte P.

    المساهمون: Danesi, R., Fogli, S., Indraccolo, S., Del Re, M., Dei Tos, A. P., Leoncini, L., Antonuzzo, L., Bonanno, L., Guarneri, V., Pierini, A., Amunni, G., Conte, P.

    مصطلحات موضوعية: biomarker, cancer, Molecular Tumor Board, oncogenic driver, target therapy

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33540286; info:eu-repo/semantics/altIdentifier/wos/WOS:000644690600001; volume:6; issue:2; firstpage:1; lastpage:14; numberofpages:14; journal:ESMO OPEN; http://hdl.handle.net/11365/1143211Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85100672005; https://www.sciencedirect.com/science/article/pii/S2059702920329069Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859305Test/

    الإتاحة: https://doi.org/10.1016/j.esmoop.2020.100040Test
    http://hdl.handle.net/11365/1143211Test
    https://www.sciencedirect.com/science/article/pii/S2059702920329069Test
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859305Test/

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients.

    المؤلفون: Del Re M, Omarini C, Diodati L, Palleschi M, Meattini I, Crucitta S, Lorenzini G, Isca C, Fontana A, Livi L, Piacentini F, Fogli S, De Giorgi U, Danesi R.

    المساهمون: Del Re, M, Omarini, C, Diodati, L, Palleschi, M, Meattini, I, Crucitta, S, Lorenzini, G, Isca, C, Fontana, A, Livi, L, Piacentini, F, Fogli, S, De Giorgi, U, Danesi, R.

    مصطلحات موضوعية: PFS, breast cancer, drug-drug interaction, palbociclib, proton pump inhibitors

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34509802; info:eu-repo/semantics/altIdentifier/wos/WOS:000704803800029; volume:6; issue:5; firstpage:1; lastpage:2; journal:ESMO OPEN; http://hdl.handle.net/11380/1253159Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85120344625

    الإتاحة: https://doi.org/10.1016/j.esmoop.2021.100231Test
    http://hdl.handle.net/11380/1253159Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    ErbB in NSCLC as a molecular target: Current evidences and future directions

    المؤلفون: Del Re M., Cucchiara F., Petrini I., Fogli S., Passaro A., Crucitta S., Attili I., De Marinis F., Chella A., Danesi R.

    المساهمون: Del Re, M., Cucchiara, F., Petrini, I., Fogli, S., Passaro, A., Crucitta, S., Attili, I., De Marinis, F., Chella, A., Danesi, R.

    مصطلحات موضوعية: Erbb, Liquid biopsy, NSCLC, Radiomic, TKIs

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32820012; info:eu-repo/semantics/altIdentifier/wos/WOS:000564366600011; volume:5; issue:4; numberofpages:11; journal:ESMO OPEN; https://hdl.handle.net/11568/1053760Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85089769224; https://www.esmoopen.com/article/S2059-7029Test(20)32643-0/fulltext

    الإتاحة: https://doi.org/10.1136/esmoopen-2020-000724Test
    https://hdl.handle.net/11568/1053760Test
    https://www.esmoopen.com/article/S2059-7029Test(20)32643-0/fulltext

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    239P Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients

    المؤلفون: Del Re, M., Omarini, C., Diodati, L., Palleschi, M., Meattini, I., Crucitta, S., Isca, C., Fogli, S., Bleve, S., Lorenzini, G., Fontana, A., Livi, L., Piacentini, F., De Giorgi, U., Danesi, R.

    المصدر: Annals of Oncology ; volume 32, page S463-S464 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/j.annonc.2021.08.522Test
    https://api.elsevier.com/content/article/PII:S0923753421027514?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753421027514?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث